SynthesisBMC public health2026
Comprehensive review of carbonated soft drink consumption rates and their public health importance.
Synthesis in BMC public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Factors Influencing Water and Sweet Beverage Purchasing Decisions and Behaviours Among Low-Income Households in Four Peri-Urban Communities in Accra: An Exploratory Study.International journal of environmental research and public health · 2026Article
- Association Between Food Environment Characteristics and Overweight and Anemia in Socially Vulnerable Children Living in Favelas.International journal of environmental research and public health · 2026Article
- Beverage Intake Patterns in a National Sample of Polish Adolescents: PLACE-19 Study.Nutrients · 2026Article
- Lifestyle behavior clusters and their associations with depressive symptoms among Chinese adolescents: during and after COVID-19 period.Health psychology and behavioral medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Excessive consumption of carbonated soft drinks (CSDs) is associated with significant public health consequences, including increased risk of obesity, type 2 diabetes, cardiovascular diseases, hypertension, and reduced bone mineral density. Daily consumption of sugar-sweetened beverages (SSBs) is linked to a 27% higher risk of type 2 diabetes (RR = 1.27) and a 9% increased risk of cardiovascular disease (RR = 1.09). Each additional daily serving contributes to an average weight gain of 0.42 kg in adults and a 14% higher likelihood of overweight and obesity among adolescents (OR = 1.14). These outcomes arise largely from the high sugar content of CSDs, poor dietary patterns, and displacement of healthier beverages. Risks are particularly pronounced among children, adolescents, and lower-income populations due to targeted marketing, socioeconomic disparities, and increased exposure to unhealthy beverages. CSD consumption has also been linked to psychosocial impacts, including increased risk of depression in women (OR = 1.36) and associations with risky behaviors among adolescents. A range of public health interventions has been introduced to reduce CSD intake. Evidence demonstrates that Mexico's soda tax reduced purchases by 12% in the first year, while Chile's restrictions on child-targeted beverage marketing effectively reduced consumption among high-risk groups. School and workplace initiatives promoting healthier beverages also support behavior change. Educational campaigns and broader policy measures continue to influence awareness and consumption patterns. This review synthesizes current evidence on the health consequences of CSD consumption, evaluates the effectiveness of interventions, and highlights research needs, with emphasis on long-term outcomes of CSD alternatives and policy impacts on vulnerable populations.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.